Stock screener

STRO

Conviction 16HealthcareScan · Thu, Sep 24, 2026

Sutro Biopharma, Inc. (STRO) closed at $15.71 (-0.13%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 28, RS Rating 90, -61.6% from its 52-week high, +43.3% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

STRO$15.71-0.13%
ResistanceSupportVol 14
63 bars
Vol MA14 399.03K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
SUTRO BIOPHARMA, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.sutrobio.com ↗
Price15.71
Change-0.13%
Gap-0.13%
Rel volume1.19×
Avg volume320.69K
Avg $ vol5.45M
SMA 2017.99
SMA 5021.07
SMA 20022.77
Price vs 50-25.44%
Price vs 200-31.02%
MA stackbearish
50/200 crossdeath · 5d
Supertrenddown · 18.91
RSI (14)28
MACD hist-0.01
MACD cross—
Stoch %K / %D16 / 17
ADX (14)53
+DI / −DI9 / 34
RSI divergence—
MACD divergence—
ATR %7.80%
ADR %5.84%
52w high40.91
52w low8.49
From 52w high-61.60%
Above 52w low+85.04%
New 52w highNo
SqueezeOff
Bollinger width46.76%
%B0.23
Donchian pos13.16%
Donchian high21.68
Donchian low14.81
AVWAP (52w high)25.24
vs AVWAP high-37.77%
AVWAP (52w low)24.42
vs AVWAP low-35.66%
OBV trendDown
Chaikin MF (20)0.00
Today vs 20d1.19×
Avg vol (14d)399.03K
Avg vol (20d)320.69K
Avg $ vol (20d)5.45M
Market cap260.49M
RS Rating90 / 99
RS 3m (vs SPY)-51.33%
RS 6m (vs SPY)-49.95%
RS line new highNo
Trend template3/8
Technical rank8.8
1 week+1.49%
1 month-26.73%
3 months-46.84%
6 months-33.13%
1 year+58.04%
YTD+43.34%
P/E-1.36
P/B-2.52
P/S2.54
P/FCF-1.46
EPS-22.49
Div yield—
ROE184.95%
ROA-98.26%
Debt/Eq-0.04
Current3.32
EV/EBITDA-1.39
Gross margin—
Net margin-186.45%
Rev growth65.18%
EPS growth15.99%
Price target51.17
Target upside225.72%
Analyst ratingBuy
Institutional101.84%
Ent. value210.22M
Revenue9.84M
Net income-38.53M
Gross profit—
Free cash flow-178.79M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out16.57M
Employees133
ListedThu, Sep 27, 2018
Free float15.56M
Float %93.9%
Short interest1.81M
Days to cover8.5d
Short volume74.1%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$2.33 vs −$2.04
Last surprise-14.2% miss
Setup gradeD
Conviction16 / 100
Pattern quality—
Tech rank8.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance26.32
Support16.59
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in STRO

All disclosures →
No recent disclosed trades by Congress in STRO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in STRO

InsiderSideShares
Hunter Heidi
Director · Stock Option (right to buy) · 2026-06-05
Grant10K
Petree Daniel H
Director · Stock Option (right to buy) · 2026-06-05
Grant10K
MATSUI CONNIE
Director · Stock Option (right to buy) · 2026-06-05
Grant10K
Jagpal Sukhi
Director · Stock Option (right to buy) · 2026-06-05
Grant10K
PANEK JAMES P
Director · Stock Option (right to buy) · 2026-06-05
Grant10K
Wigginton Jon Marc
Director · Stock Option (right to buy) · 2026-06-05
Grant10K
Dybbs Michael
Director · Stock Option (right to buy) · 2026-06-05
Grant10K
Lobacki Joseph M
Director · Stock Option (right to buy) · 2026-06-05
Grant10K
Chow Gregory K.
CFO · Restricted Stock Units (RSUs) · 2026-06-02
Exercise2.5K
Chow Gregory K.
CFO · Common Stock · 2026-06-02
Exercise2.5K

SEC filings

EDGAR filings in STRO · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.